Grant: Alliance Grants
University of Saskatchewan
$26,955.00
Surveillance of antibiotic-resistant enteric pathogens, their relationship with antibiotic use in broiler chicken farms in Atlantic Canada, and antibiotic alternative intervention
EF 2024-25
Résumé
Antimicrobial resistance (AMR) is a major public health problem that threatens the effective prevention and treatment of an ever-increasing range of microbial infections. In 2019, 4.95 million deaths were associated with AMR. The WHO has indicated that in addition to death and disability, AMR causes significant losses to the economy in terms of prolonged illness resulting in longer hospital stays, the need for more expensive drugs and specialized equipment, and financial challenges for those impacted. It has been estimated that nontherapeutic livestock use accounts for 70% of total antimicrobial use (AMU), 43% of which is given to chickens, making AMU in chickens a major contributor to AMR. In Canada, chicken farm-level AMR/AMU surveillance has been limited to selected provinces (BC, ON, QC, and the Prairies), with no surveillance done in Atlantic Canada (AC). However, recent reports have indicated that AMR patterns differ among geographical regions within a nation. The chicken gastrointestinal tract also harbours bacteria (Salmonella and Campylobacter) that are deadly to humans and can readily contaminate the environment; thus, the lack of AMR/AMU surveillance data is an important gap and a risk to public health and food safety. The Canadian Poultry Research Council and Probiotech International Incorporation identified the need for research to characterize enteric pathogens, determine AMR and AMU and their relationships, develop an antibiotic alternative as an intervention strategy, and assess the impact of the intervention in broiler chicken farms in AC via a partnership with the Applicant. This project will result in a demonstration of commitment to food safety and increase consumer confidence, thereby enhancing the competitiveness and profitability of AC and Canada's poultry sector. It will reduce AMU and AMR through the development of an antibiotic alternative, thus contributing to the much-needed solution to the problem of AMR that causes over 14,000 human deaths every year in Canada and the associated burden on the economy. 1 PhD, 1 undergraduate, and 1 Technician will be trained through the project.
Programme
Alliance Grants
Bénéficiaire
Emplacement
Saskatchewan, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
591024-2023
Name nom
Adewole, Deborah DI
Department département
Animal and Poultry Science
Organization id
16
Institution établissement
University of Saskatchewan
Province en
Saskatchewan
Province fr
Saskatchewan
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2023
Award amount
26955
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
102
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Animal management (animal diseases, breeding)
Area of application fr
Gestion des animaux (maladies animales, reproduction)
Research subject code
5512
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Veterinary sciences
Research subject fr
Médecine vétérinaire
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Surveillance of antibiotic-resistant enteric pathogens, their relationship with antibiotic use in broiler chicken farms in Atlantic Canada, and antibiotic alternative intervention
Keywords
antibiotic alternative intervention; antibiotic resistance; antibiotic use; atlantic canada; broiler chicken flocks; campylobacter; enteric pathogens; escherichia coli; on-farm surveillance; salmonella
Application summary
Antimicrobial resistance (AMR) is a major public health problem that threatens the effective prevention and treatment of an ever-increasing range of microbial infections. In 2019, 4.95 million deaths were associated with AMR. The WHO has indicated that in addition to death and disability, AMR causes significant losses to the economy in terms of prolonged illness resulting in longer hospital stays, the need for more expensive drugs and specialized equipment, and financial challenges for those impacted. It has been estimated that nontherapeutic livestock use accounts for 70% of total antimicrobial use (AMU), 43% of which is given to chickens, making AMU in chickens a major contributor to AMR. In Canada, chicken farm-level AMR/AMU surveillance has been limited to selected provinces (BC, ON, QC, and the Prairies), with no surveillance done in Atlantic Canada (AC). However, recent reports have indicated that AMR patterns differ among geographical regions within a nation. The chicken gastrointestinal tract also harbours bacteria (Salmonella and Campylobacter) that are deadly to humans and can readily contaminate the environment; thus, the lack of AMR/AMU surveillance data is an important gap and a risk to public health and food safety. The Canadian Poultry Research Council and Probiotech International Incorporation identified the need for research to characterize enteric pathogens, determine AMR and AMU and their relationships, develop an antibiotic alternative as an intervention strategy, and assess the impact of the intervention in broiler chicken farms in AC via a partnership with the Applicant. This project will result in a demonstration of commitment to food safety and increase consumer confidence, thereby enhancing the competitiveness and profitability of AC and Canada's poultry sector. It will reduce AMU and AMR through the development of an antibiotic alternative, thus contributing to the much-needed solution to the problem of AMR that causes over 14,000 human deaths every year in Canada and the associated burden on the economy. 1 PhD, 1 undergraduate, and 1 Technician will be trained through the project.